Guidance
Update information
July 2022: We updated the guidance again in July 2022 to reflect new evidence and updated costs. These updates are marked [2022]. Details of the changes are explained in the review decision from June 2022.
February 2018: Having originally been developed to make recommendations on the use of VeriQ, this guidance has been updated to make recommendations on the use of a follow-on technology, MiraQ. The recommendations, committee considerations and evidence for VeriQ apply to the new technology. The technology name has been changed where relevant from VeriQ to MiraQ. New evidence and updated costs identified during the guidance review are denoted as [2018].
ISBN: 978-1-4731-1174-5